No Data
No Data
Pfizer Gains FDA Approval for Colorectal-Cancer Treatment
Friday Market Rebounds Some of Weeks Loss | Wall Street Today
Pfizer Gets FDA Accelerated Approval for Braftovi
FDA Grants Accelerated Approval To Encorafenib With Cetuximab And MFOLFOX6 For Metastatic Colorectal Cancer With A BRAF V600E Mutation
Government Shutdown Threat: Stocks Wobble, Holiday Travel And Paychecks Could Face Delays: What You Need To Know
EXCLUSIVE: Weight-Loss Market Experts Scoop Up Novo Nordisk Stock After Worst Drop Since 2002 Following Drug Trial Miss